Mercy BioAnalytics, Inc. Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Mercy BioAnalytics, Inc. is a biotechnology research company based in Waltham, Massachusetts. It focuses on cancer detection by developing a liquid biopsy platform that analyzes tumor-derived extracellular vesicles circulating in blood, which carry information about the tumor cells of origin and can indicate cancer at very early stages. The approach relies on non-invasive blood-based signals to enable earlier and more accurate diagnosis, aligning with the stated mission to save lives and relieve suffering globally. The company operates within the biotechnology and oncology diagnostics space, pursuing early detection solutions.

Details about the company’s customers or target market are not specified in the provided information. A recent development includes the appointment of Darrin Crisitello as Chief Commercial Officer in February 2026, signaling an emphasis on commercial strategy.

Sign up for free to view info

Company overview Employee directory